BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 30915771)

  • 1. Circulating miRNAs as biomarkers in cardiovascular diseases.
    Kaneto CM; Nascimento JS; Prado MSJG; Mendonça LSO
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2234-2243. PubMed ID: 30915771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic Biomarkers and Cardiovascular Disease: Circulating MicroRNAs.
    de Gonzalo-Calvo D; Iglesias-Gutiérrez E; Llorente-Cortés V
    Rev Esp Cardiol (Engl Ed); 2017 Sep; 70(9):763-769. PubMed ID: 28623159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs as Candidate Drug Targets for Cardiovascular Diseases.
    Hang P; Guo J; Sun C; Du Z
    Curr Drug Targets; 2017; 18(4):463-472. PubMed ID: 26926467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges.
    Zhou SS; Jin JP; Wang JQ; Zhang ZG; Freedman JH; Zheng Y; Cai L
    Acta Pharmacol Sin; 2018 Jul; 39(7):1073-1084. PubMed ID: 29877320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenges in Using Circulating Micro-RNAs as Biomarkers for Cardiovascular Diseases.
    Felekkis K; Papaneophytou C
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31952319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small Molecules with Big Impacts on Cardiovascular Diseases.
    Mirzadeh Azad F; Arabian M; Maleki M; Malakootian M
    Biochem Genet; 2020 Jun; 58(3):359-383. PubMed ID: 31997044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA and Cardiovascular Diseases.
    Çakmak HA; Demir M
    Balkan Med J; 2020 Feb; 37(2):60-71. PubMed ID: 32018347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis, prognosis and therapeutic role of circulating miRNAs in cardiovascular diseases.
    Sayed AS; Xia K; Salma U; Yang T; Peng J
    Heart Lung Circ; 2014 Jun; 23(6):503-10. PubMed ID: 24726001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of miR-214 in cardiovascular diseases.
    Zhao Y; Ponnusamy M; Zhang L; Zhang Y; Liu C; Yu W; Wang K; Li P
    Eur J Pharmacol; 2017 Dec; 816():138-145. PubMed ID: 28842125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs as biomarkers for clinical studies.
    Pogribny IP
    Exp Biol Med (Maywood); 2018 Feb; 243(3):283-290. PubMed ID: 28914096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. microRNAs in cardiovascular disease - clinical application.
    Schulte C; Karakas M; Zeller T
    Clin Chem Lab Med; 2017 May; 55(5):687-704. PubMed ID: 27914211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of miRNAs on the Pathophysiology of Cardiovascular Diseases.
    Silva DCPD; Carneiro FD; Almeida KC; Fernandes-Santos C
    Arq Bras Cardiol; 2018 Nov; 111(5):738-746. PubMed ID: 30484515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating microRNAs in cardiovascular diseases: from biomarkers to therapeutic targets.
    Wang F; Chen C; Wang D
    Front Med; 2014 Dec; 8(4):404-18. PubMed ID: 25445171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNAs in cardiovascular disease: an introduction for clinicians.
    Romaine SP; Tomaszewski M; Condorelli G; Samani NJ
    Heart; 2015 Jun; 101(12):921-8. PubMed ID: 25814653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miRNAs as potential therapeutic targets and diagnostic biomarkers for cardiovascular disease with a particular focus on WO2010091204.
    Yang Y; Yu T; Jiang S; Zhang Y; Li M; Tang N; Ponnusamy M; Wang JX; Li PF
    Expert Opin Ther Pat; 2017 Sep; 27(9):1021-1029. PubMed ID: 28627982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations of circulating cell-free microRNA with vasculopathy and vascular events in systemic lupus erythematosus patients.
    Kay SD; Carlsen AL; Voss A; Burton M; Diederichsen A; Poulsen MK; Heegaard N
    Scand J Rheumatol; 2019 Jan; 48(1):32-41. PubMed ID: 29985728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. microRNAs as promising biomarkers of platelet activity in antiplatelet therapy monitoring.
    Krammer TL; Mayr M; Hackl M
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32423125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of circulating microRNAs as markers in detecting and predicting congenital heart defects in children.
    Song Y; Higgins H; Guo J; Harrison K; Schultz EN; Hales BJ; Moses EK; Goldblatt J; Pachter N; Zhang G
    J Transl Med; 2018 Feb; 16(1):42. PubMed ID: 29482591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs: role in cardiovascular biology and disease.
    Zhang C
    Clin Sci (Lond); 2008 Jun; 114(12):699-706. PubMed ID: 18474027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs: roles in cardiovascular development and disease.
    Kalayinia S; Arjmand F; Maleki M; Malakootian M; Singh CP
    Cardiovasc Pathol; 2021; 50():107296. PubMed ID: 33022373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.